Endo to supply Vasostrict through Premier

Endo’s Par Sterile Products business will supply Vasostrict, vasopressin injection, vial presentations to healthcare providers through Premier's Premier ProRx program, helping to maintain supply continuity for a medication needed in critical care, including some of the most acute cases of COVID-19.

"We're pleased to join Premier in addressing industry drug shortages and serving as a guaranteed supplier of Vasostrict—proudly produced in our Rochester, Mich. facility," said Scott Sims, senior vice president and general manager of sterile injectables at Endo.

[Read more: Strides completes acquisition of Endo's U.S. manufacturing facility]

Sims added, "As a longstanding Premier partner, we welcome the opportunity to work with them via their Premier ProRx program to offer Vasostrict through their robust and highly reliable supply channel."

[Read more: State of the Pharmacy 2021: Executives weigh in]